Have we applied? I have never heard that we ask for any

New Post Public Reply Private Reply Replies (3) Message Board
blafarm flyntrade #45055
948
Quote:
Have we applied? I have never heard that we ask for any assistance.
That's a fair question.

I think you are saying that the government cannot force a private company to accept funding. And we all know that there are compelling reasons to NOT take money as I believe it conveys rights and privileges to the funder that may be antithetical to a small company's business model. And yet I find myself wondering why Big Pharma never seems to have a problem with that part of the equation.

Anyway, that still begs the question of why the FDA / government did not at least help us to enroll our trials, or buy all of the available (or future) inventory as they did with Regeneron -- especially in the face of our eIND results. Let's face it, the US is going to buy it anyway, and CytoDyn could have used the money to advance the trials or order more product from Samsung.

It is clear that the US government is throwing money around like a drunken sailor. And they have been doing it as far back, if not before, when they tried to buy German vaccine maker CureVac for an unlimited amount of money.

Source Link: https://www.marketwatch.com/story/germany-inv...2020-06-15

The stakes could not be higher. This pandemic is a national security issue, and the fate of our economy (not to mention, the world's) hinges on a therapeutic or vaccine. There is no exaggeration or hyperbole in the previous statements.

If leronlimab is approved, the US will not only want enough doses to treat Americans with the virus -- it will want to build a massive stockpile that can be used to address the very real possibility that a vaccine may not be possible, or may only offer protection for a matter of months. This virus could last for the rest of our lives.

And once the government begins to understand that leronlimab is a broad-based therapeutic whose MOA is virus-agnostic, and therefore applicable to future viruses and pandemics that have not even hit our shores, the desire to build a stockpile will increase exponentially.

And the exact same realization will happen in every nation in the world.

I have quietly observed various posters (on this board and others) stating that leronlimab order for COVID indication will never reach the hundreds of millions of doses. In my opinion, that is one of the most short-sighted statements I have ever heard.

Our country alone will want hundreds of millions of doses, for the current pandemic (which might last for years -- or might last for the rest of our lives), and for the next pandemic which hasn't even arrived yet. And then there's the very possible use of leronlimab for prophylaxis and post-virus "long haulers". Now, multiply that out by the number of other countries in the world.

If one cannot envision how COVID orders could be in the hundreds of millions -- then you're not living in my version of reality.

Setting aside your very reasonable point regarding CytoDyn's application (or not) for funding, why would't the government have at least helped to increase trial enrollment, increase production, or make offers to buy all of the available product for the foreseeable future?

The only explanation I can think of is that Dr.NP has been lying to us about the progressively dwindling production numbers he's been stating. He started in April with a potential 5 million vials supplied by Samsung and 600-700k from AGC. Now he's telling us it is 1.1 million from Samsung and AGC is nowhere to be found.

Are we to believe the 4 million missing vials have been quietly allocated to the the US? I doubt it. I think time dragged on, money got tight, Samsung booked their bioreactors in the absence of any firm orders (other than the one that Dr.NP allegedly helped to fund), and who knows what happened to AGC (there's something wrong with that, especially since Dr.NP has somehow decided to not discuss this anymore).

So, funding aside, with eIND results that any other Big Pharmaceutical company would pay billions to have for themselves -- why is CytoDyn barely able to enroll their trials, and why are they only able to provide 1.1M vials this year?

In the face of extraordinary suffering and death, and an economy literally teetering on ruin, this entire scenario makes absolute no sense to me.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 4

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 7

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 5

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 10

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 6

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading

Top 5 Most Recently Viewed Articles

Russell 2000 Hits New Heights as Market's Confidence Grows

Updated Category News Views 168

Russell 2000 Achieves New Milestone in Bull Market The Russell 2000 index has made a remarkable push, reaching a new closing high and signifying a positive momentum in the ongoing bull market. This achievement illustrates its significant journey over the past three years, contributing to the broader market dynamics since the inception of the bull market that began in...

Continue Reading
TEN Holdings Partners with Firm to Enhance Global Broadcasts

Updated Category News Views 102

TEN Holdings and its Innovative Webcasting Solutions TEN Holdings, Inc. (NASDAQ: XHLD), recognized for its event planning, production, and broadcasting services, is making significant strides in the digital broadcasting landscape. With a commitment to delivering cutting-edge solutions, TEN Holdings has emerged as a trusted technical partner for a leading consulting firm...

Continue Reading
Immutable Achieves Historic Milestone in Gaming Growth

Updated Category News Views 201

Immutable Achieves Historic Milestone in Gaming Growth Setting New Records in 2024 Immutable has officially emerged as the leading name in web3 gaming, marking a significant year in 2024. The company surpassed a remarkable milestone by onboarding over 250 new games, a number greater than all previous years combined. This explosive growth reinforces its position as the...

Continue Reading
Future Prospects for The Beachbody Company, Inc. Stock

Updated Category News Views 154

Upcoming Earnings Announcement for The Beachbody Company The Beachbody Company, Inc. Class A Common Stock (NYSE: BODI) is set to announce its quarterly earnings. Investors and analysts alike are eagerly looking forward to this event, as it holds significant implications for the stock's future trajectory. Estimated Earnings Per Share Analysts project that The Beachbody...

Continue Reading
Understanding Market Sentiments Around TransMedics Gr's Stock

Updated Category News Views 96

Understanding Market Sentiments Around TransMedics Gr's Stock TransMedics Gr (NYSE: TMDX) has recently made headlines as its short percent of float has seen a significant rise, increasing by 9.45% since its last report. The company currently has 6.02 million shares sold short, which represents 22.0% of all shares available for trading. Analysts have calculated that, at...

Continue Reading